Pluripotency transcription factors in lung cancer—a review-Reference-Cited by-同舟云学术

Pluripotency transcription factors in lung cancer—a review

Published:2015-11-18 Issue:4 Volume:37 Page:4241-4249
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Sławek Sylwia,Szmyt Krzysztof,Fularz Maciej,Dziudzia Joanna,Boruczkowski Maciej,Sikora Jan,Kaczmarek Mariusz

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-015-4407-x.pdf

Reference87 articles.

1. Gibson G, Loddenkemper R, Sibille Y, Lundbäck B. The European lung white book: sheffield; 2013. p. 224–235.

2. Wojciechowska U, Didkowska J. Zachorowania i zgony na nowotwory złośliwe w Polsce. Krajowy Rejestr Nowotworów, Centrum Onkologii - Instytut im. Marii Skłodowskiej - Curie. http://onkologia.org.pl/raporty/ Accessed 31.Oct 2015.

3. Qu H, Li R, Liu Z, Zhang J, Luo R. Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic review. Int J Clin Exp Pathol. 2013;6(11):2644–50.

4. Tan Y, Chen B, Xu W, Zhao W, Wu J. Clinicopathological significance of CD133 in lung cancer: a meta-analysis. Mol Clin Oncol. 2014;2(1):111–5.

5. Succony L, Janes SM. Airway stem cells and lung cancer. QJM. 2014;107(8):607–12.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison between Recurrent and Non-Recurrent Patient-Derived CAFs;Cancer Investigation;2023-07-23

2. miRNA-204-5p acts as tumor suppressor to influence the invasion and migration of astrocytoma by targeting ezrin and is downregulated by DNA methylation;Bioengineered;2021-11-24

3. Cell Populations Expressing Stemness-Associated Markers in Lung Adenocarcinoma;Life;2021-10-18

4. Melatonin and its derivative disrupt cancer stem‐like phenotypes of lung cancer cells via AKT downregulation;Clinical and Experimental Pharmacology and Physiology;2021-08-31

5. Pluripotency inducing Yamanaka factors: role in stemness and chemoresistance of liver cancer;Expert Review of Anticancer Therapy;2021-05-06